October was another busy month in Huntington’s disease (HD) research! We learned more about often-overlooked symptoms, ...
The FDA has accepted uniQure’s application for AMT-130 (now called ifezuntirgene inilparvovec), an experimental gene therapy ...
An experimental treatment for HD developed by Alnylam has shown long-lasting huntingtin lowering after just one dose, with ...
In plain language. Written by scientists. For the global HD community.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results